Pharmaceutical officials refuse to meet with Trump following rule lowering drug prices

Drug industry lobbyists refused to attend a scheduled White House meeting with President Trump Tuesday to discuss his new rule limiting drug prices, forcing the White House to cancel the session.


Read More